Ondrej Kubecek

Hradec Kralove, KR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases.

Genetic differences between primary colorectal cancer and its paired synchronous and metachronous metastases.

Journal: International journal of cancer

Published: January 24, 2025

The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.

The outcome in patients with BRAF-mutated metastatic melanoma treated with anti-programmed death receptor-1 monotherapy or targeted therapy in the real-world setting.

Journal: Cancer medicine

Published: July 08, 2023

The dynamics of telomere length in primary and metastatic colorectal cancer lesions.

The dynamics of telomere length in primary and metastatic colorectal cancer lesions.

Journal: Scientific reports

Published: January 11, 2023

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer.

Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer.

Journal: Frontiers in oncology

Published: December 29, 2022

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes.

MUC13-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes.

Journal: Oncology letters

Published: August 04, 2022

Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Risk Factors for Infections, Antibiotic Therapy, and Its Impact on Cancer Therapy Outcomes for Patients with Solid Tumors.

Journal: Life (Basel, Switzerland)

Published: November 29, 2021

Combined Therapy of Locally Advanced Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors.

Combined Therapy of Locally Advanced Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas: State of the Art and Aspects of Predictive Factors.

Journal: Cancers

Published: August 08, 2021

Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer.

Clinicopathological Characteristics and Prognostic Factors in Ovarian Metastases from Right- and Left-Sided Colorectal Cancer.

Journal: Current oncology (Toronto, Ont.)

Published: July 05, 2021

Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors.

Administration of Nivolumab in Metastatic Renal Cell Cancer Following Treatment With mTOR Inhibitors.

Journal: In vivo (Athens, Greece)

Published: June 08, 2021

Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma.

Prognostic value of blood cell count-derived ratios in BRAF-mutated metastatic melanoma.

Journal: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Published: April 18, 2021

Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940.

Erratum: Filip, S.; et al. Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years. Pharmaceutics 2020, 12, 940.

Journal: Pharmaceutics

Published: October 28, 2020

Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years.

Therapeutic Apheresis, Circulating PLD, and Mucocutaneous Toxicity: Our Clinical Experience through Four Years.

Journal: Pharmaceutics

Published: July 09, 2020

Showing 1-12 of 28

Last Updated: 09/26/2026